You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 8, 2025

List of Excipients in API levetiracetam


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing levetiracetam

Glossary
CompanyTradenameIngredientNDCExcipientPotential Generic Entry
STAT RX USA LLC KEPPRA levetiracetam 16590-134 CROSCARMELLOSE SODIUM
STAT RX USA LLC KEPPRA levetiracetam 16590-134 FERRIC OXIDE YELLOW
STAT RX USA LLC KEPPRA levetiracetam 16590-134 MAGNESIUM STEARATE
STAT RX USA LLC KEPPRA levetiracetam 16590-134 POLYETHYLENE GLYCOL 3350
>Company>Tradename>Ingredient>NDC>Excipient>Potential Generic Entry

Subscribe to access the full database, or Try for Free

Showing 1 to 4 of 4 entries

Excipients in ANDA-approved (generic) drugs containing levetiracetam

Detailed excipient profiles for levetiracetam

Excipient focus: ACESULFAME POTASSIUM

Excipient focus: ACETIC ACID

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM OXIDE

Excipient focus: AMMONIA

Excipient focus: AMMONIUM GLYCYRRHIZATE

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BUTYL ALCOHOL

Excipient focus: BUTYLATED HYDROXYANISOLE

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

levetiracetam drug variants containing CELLULOSE, MICROCRYSTALLINE

Excipient focus: CETOSTEARYL ALCOHOL

Excipient focus: CHERRY

Excipient focus: CI 77891

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: COPOVIDONE

Excipient focus: COPOVIDONE K25-31

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C RED NO. 27

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: DIBUTYL SEBACATE

Excipient focus: DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER

levetiracetam drug variants not containing DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER

Excipient focus: ETHYLCELLULOSE

Excipient focus: ETHYLCELLULOSES

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C BLUE NO. 2 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GLYCERIN

Excipient focus: GLYCYRRHIZIN

Excipient focus: GRAPE

Excipient focus: HYDROGENATED CASTOR OIL

Excipient focus: HYDROGENATED COTTONSEED OIL

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: INDIGOTINDISULFONATE SODIUM

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: KAOLIN

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTITOL

Excipient focus: MANNITOL

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

Excipient focus: METHYL ALCOHOL

Excipient focus: METHYLPARABEN

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: OLEIC ACID

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 800

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 20

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

levetiracetam drug variants containing POLYVINYL ALCOHOL

Excipient focus: POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER

levetiracetam drug variants not containing POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: POVIDONE K90

Excipient focus: POVIDONES

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SHELLAC

Excipient focus: SILICA

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM ACETATE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SORBITOL

Excipient focus: SORBITOL SOLUTION

Excipient focus: SPEARMINT

Excipient focus: STARCH, CORN

levetiracetam drug variants containing STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: SUCRALOSE

Excipient focus: SUCROSE

Excipient focus: TALC

levetiracetam drug variants containing TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Excipient focus: WATER O-18

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group